BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 17845118)

  • 1. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS).
    Watson D; O'Hara MW; Simms LJ; Kotov R; Chmielewski M; McDade-Montez EA; Gamez W; Stuart S
    Psychol Assess; 2007 Sep; 19(3):253-68. PubMed ID: 17845118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further validation of the IDAS: evidence of convergent, discriminant, criterion, and incremental validity.
    Watson D; O'Hara MW; Chmielewski M; McDade-Montez EA; Koffel E; Naragon K; Stuart S
    Psychol Assess; 2008 Sep; 20(3):248-59. PubMed ID: 18778161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of new anxiety and bipolar symptom scales for an expanded version of the IDAS (the IDAS-II).
    Watson D; O'Hara MW; Naragon-Gainey K; Koffel E; Chmielewski M; Kotov R; Stasik SM; Ruggero CJ
    Assessment; 2012 Dec; 19(4):399-420. PubMed ID: 22822173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation study of the Depressive Experience Questionnaire].
    Atger F; Frasson G; Loas G; Guibourgé S; Corcos M; Perez Diaz F; Speranza M; Venisse JL; Lang F; Stephan P; Bizouard P; Flament M; Jeammet P
    Encephale; 2003; 29(5):445-55. PubMed ID: 14615694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
    Carleton RN; Collimore KC; Asmundson GJ
    J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parsing the general and specific components of depression and anxiety with bifactor modeling.
    Simms LJ; Grös DF; Watson D; O'Hara MW
    Depress Anxiety; 2008; 25(7):E34-46. PubMed ID: 18027844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminant and convergent validity of self-report measures of affective distress in patients with rheumatoid arthritis.
    Hagglund KJ; Roth DL; Haley WE; Alarcón GS
    J Rheumatol; 1989 Nov; 16(11):1428-32. PubMed ID: 2600941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of psychometric properties of two new questionnaires assessing beliefs in hypochondriasis in a non-clinical population].
    Pelletier O; Gosselin P; Langlois F; Ladouceur R
    Encephale; 2002; 28(4):298-309. PubMed ID: 12232539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short version of the Depression Anxiety Stress Scales (DASS-21): factor structure in a young adolescent sample.
    Szabó M
    J Adolesc; 2010 Feb; 33(1):1-8. PubMed ID: 19560196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative self-portrayal scale: development, validation, and application to social anxiety.
    Moscovitch DA; Huyder V
    Behav Ther; 2011 Jun; 42(2):183-96. PubMed ID: 21496505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A depressive symptom scale for the California Psychological Inventory: construct validation of the CPI-D.
    Jay M; John OP
    Psychol Assess; 2004 Sep; 16(3):299-309. PubMed ID: 15456385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ).
    Wardenaar KJ; van Veen T; Giltay EJ; de Beurs E; Penninx BW; Zitman FG
    Psychiatry Res; 2010 Aug; 179(1):101-6. PubMed ID: 20472297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Injury Distress Index: development and validation.
    Victorson DE; Enders CK; Burnett KF; Ouellette EA
    Arch Phys Med Rehabil; 2008 Oct; 89(10):1893-902. PubMed ID: 18929018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Depression Profile: a new psychometric instrument to selectively evaluate depressive symptoms based on the neurocircuitry theory.
    Faludi G; Gonda X; Kliment E; Bekes V; Mészáros V; Oláh A
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):337-45. PubMed ID: 20606243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and testing of the depression, anxiety, and positive outlook scale (DAPOS).
    Pincus T; Williams AC; Vogel S; Field A
    Pain; 2004 May; 109(1-2):181-8. PubMed ID: 15082140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimensionality of somatic complaints: factor structure and psychometric properties of the Self-Rating Anxiety Scale.
    Olatunji BO; Deacon BJ; Abramowitz JS; Tolin DF
    J Anxiety Disord; 2006; 20(5):543-61. PubMed ID: 16198532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empathy and symptoms dimensions of patients with obsessive-compulsive disorder.
    Fontenelle LF; Soares ID; Miele F; Borges MC; Prazeres AM; Rangé BP; Moll J
    J Psychiatr Res; 2009 Jan; 43(4):455-63. PubMed ID: 18614180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Thai Depression Inventory.
    Lotrakul M; Sukanich P
    J Med Assoc Thai; 1999 Dec; 82(12):1200-7. PubMed ID: 10659561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain-related anxiety and anxiety sensitivity across anxiety and depressive disorders.
    Carleton RN; Abrams MP; Asmundson GJ; Antony MM; McCabe RE
    J Anxiety Disord; 2009 Aug; 23(6):791-8. PubMed ID: 19362446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.